Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 27;11(1):2316.
doi: 10.1038/s41598-021-81961-7.

Inflammation and regulatory T cell genes are differentially expressed in peripheral blood mononuclear cells of Parkinson's disease patients

Affiliations

Inflammation and regulatory T cell genes are differentially expressed in peripheral blood mononuclear cells of Parkinson's disease patients

Zerrin Karaaslan et al. Sci Rep. .

Abstract

Our aim was to identify the differentially expressed genes (DEGs) in peripheral blood mononuclear cells (PBMC) of Parkinson's disease (PD) patients and healthy controls by microarray technology and analysis of related molecular pathways by functional annotation. Thirty PD patients and 30 controls were enrolled. Agilent Human 8X60 K Oligo Microarray was used for gene level expression identification. Gene ontology and pathway enrichment analyses were used for functional annotation of DEGs. Protein-protein interaction analyses were performed with STRING. Expression levels of randomly selected DEGs were quantified by real time quantitative polymerase chain reaction (RT-PCR) for validation. Flow cytometry was done to determine frequency of regulatory T cells (Tregs) in PBMC. A total of 361 DEGs (143 upregulated and 218 downregulated) were identified after GeneSpring analysis. DEGs were involved in 28 biological processes, 12 cellular components and 26 molecular functions. Pathway analyses demonstrated that upregulated genes mainly enriched in p53 (CASP3, TSC2, ATR, MDM4, CCNG1) and PI3K/Akt (IL2RA, IL4R, TSC2, VEGFA, PKN2, PIK3CA, ITGA4, BCL2L11) signaling pathways. TP53 and PIK3CA were identified as most significant hub proteins. Expression profiles obtained by RT-PCR were consistent with microarray findings. PD patients showed increased proportions of CD49d+ Tregs, which correlated with disability scores. Survival pathway genes were upregulated putatively to compensate neuronal degeneration. Bioinformatics analysis showed an association between survival and inflammation genes. Increased CD49d+ Treg ratios might signify the effort of the immune system to suppress ongoing neuroinflammation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Protein–protein interaction (PPI) network for upregulated DEGs in PI3K/Akt pathway. Nodes represent proteins and lines represent interactions of proteins in networks.
Figure 2
Figure 2
Protein–protein interaction (PPI) network for upregulated DEGs in p53 pathway. Nodes represent proteins and lines represent interactions of proteins in networks.
Figure 3
Figure 3
Frequencies of T cell subsets are shown on y axis for PD and control groups, symbol ◊ represents subjects enrolled in both RT-PCR and flow cytometry studies.
Figure 4
Figure 4
Correlation plot between total UPDRS score and proportion of CD4+CD25+CD127lowCD49d+ Tregs.

Similar articles

Cited by

References

    1. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006;5:525–535. doi: 10.1016/S1474-4422(06)70471-9. - DOI - PubMed
    1. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 1988;51:745–752. doi: 10.1136/jnnp.51.6.745. - DOI - PMC - PubMed
    1. Kalia LV, et al. Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol. 2015;72:100–105. doi: 10.1001/jamaneurol.2014.2704. - DOI - PMC - PubMed
    1. Wu Y, Le W, Jankovic J. Preclinical biomarkers of Parkinson disease. Arch. Neurol. 2011;68:22–30. doi: 10.1001/archneurol.2010.321. - DOI - PubMed
    1. Goldman SM. Environmental toxins and Parkinson's disease. Annu. Rev. Pharmacol. Toxicol. 2014;54:141–164. doi: 10.1146/annurev-pharmtox-011613-135937. - DOI - PubMed

Publication types